This is not the most recent version of the article. View current version (18 JUL 2007)

Intervention Protocol

Rosiglitazone for type 2 diabetes mellitus

  1. B Richter,
  2. E Bandeira-Echtler,
  3. K Bergerhoff,
  4. C Clar,
  5. SH Ebrahim

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 19 APR 2006

DOI: 10.1002/14651858.CD006063


How to Cite

Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim SH. Rosiglitazone for type 2 diabetes mellitus (Protocol). Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD006063. DOI: 10.1002/14651858.CD006063.

Author Information

*Dr Bernd Richter, Coordinating Editor 'Metabolic and Endocrine Disorders Cochrane Review Group', Department of Endocrinology, Diabetes and Rheumatology, Universitaetsklinikum Duesseldorf, Moorenstr. 5, Duesseldorf, 40225, GERMANY. richterb@uni-duesseldorf.de.

Publication History

  1. Published Online: 19 APR 2006

SEARCH

This is not the most recent version of the article. View current version (18 JUL 2007)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of rosiglitazone in the treatment of type 2 diabetes.